会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • COMPOSITION AND METHOD FOR THE TREATMENT OF VIRAL INFECTION USING CAMELID HEAVY CHAIN ANTIBODIES
    • 使用CAMELID重链抗体治疗病毒感染的组合物和方法
    • WO2007052242A1
    • 2007-05-10
    • PCT/IE2006/000126
    • 2006-11-03
    • PRENDERGAST, Patrick, T.
    • PRENDERGAST, Patrick, T.
    • C07K16/10
    • C07K16/1018A61K2039/505C07K2317/22C07K2317/76
    • The present invention provides a method of treating or preventing human infection with type A Influenza comprising the step of administering a therapeutically useful amount of an isolated heavy chain Camelid antibody, or an antigen binding portion thereof, to a subject in need of treatment. The invention also extends to an isolated heavy chain Camelid antibody, or an antigen binding portion thereof, for use in the prophylaxis or treatment of human infection with type A influenza. Also provided is a method of producing a polyclonal Camelid heavy chain immunoglobulin preparation which specifically binds Neuraminidase and a method of treating influenza A viral infection comprising the step of administering said immunoglobulin preparation, or an antigen-binding portion thereof, to a subject in need of therapy.
    • 本发明提供一种治疗或预​​防甲型流感的人感染的方法,包括向需要治疗的受试者施用治疗有用量的分离的重链骆驼科抗体或其抗原结合部分的步骤。 本发明还延伸到用于预防或治疗人类A型流感感染的分离的重链骆驼科动物抗体或其抗原结合部分。 还提供了一种制备特异性结合神经氨酸酶的多克隆骆驼重链免疫球蛋白制剂的方法和一种治疗甲型流感病毒感染的方法,包括将所述免疫球蛋白制剂或其抗原结合部分施用于需要 治疗。
    • 7. 发明申请
    • COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING MUCOSITIS AND WEIGHT LOSS
    • 用于预防和治疗肌瘤和重量损失的组合物和方法
    • WO2008110585A2
    • 2008-09-18
    • PCT/EP2008/052969
    • 2008-03-12
    • PRENDERGAST, Patrick T.
    • PRENDERGAST, Patrick T.
    • A61K31/497A61K31/7076A61P1/04
    • A61K31/497A61K31/4985A61K31/7076A61K45/06
    • A method for prophylaxis and/or treatment of mucositis comprising the steps of providing a therapeutically effective amount of a composition comprising either (1) at least one compound selected from the group consisting of 5-[2-pyrazinyl]-4-methyl-1,2-3-thione or an analogue, derivative, metabolite, prodrug, solvate or a pharmaceutically acceptable salt thereof; or (2) a cytokinin compound; and administering the composition to a subject in need of such treatment. Also provided are pharmaceutical compositions comprising 5-[2-pyrazinyl]-4-methyl-1,2-3- thione and/or a cytokinin compound and use of these compositions in the preparation of a medicament for the treatment and/or prophylaxis of mucositis. The cytokinin compound may be selected from, but is not limited to N 6 -isopentenyl adenosine and N 6 -benzyl adenosine. The compositions may further comprise a chemotherapeutic agent, such as cisplatin. Further provided are methods and compositions for reducing and/or preventing weight loss in subjects undergoing cancer treatment.
    • 一种预防和/或治疗粘膜炎的方法,包括以下步骤:提供治疗有效量的组合物,所述组合物包含(1)至少一种选自5- [2-吡嗪基] -4-甲基-1 2-3-硫酮或类似物,衍生物,代谢物,前药,溶剂合物或其药学上可接受的盐; 或(2)细胞分裂素化合物; 并将该组合物施用于需要这种治疗的受试者。 还提供了包含5- [2-吡嗪基] -4-甲基-1,2-3-硫酮和/或细胞分裂素化合物的药物组合物,以及这些组合物在制备用于治疗和/或预防 粘膜炎。 细胞分裂素化合物可以选自但不限于N 6 - 异戊烯基腺苷和N 6 - 苄基腺苷。 组合物还可以包含化学治疗剂,例如顺铂。 还提供了用于减少和/或预防经受癌症治疗的受试者体重减轻的方法和组合物。